Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Pneumologia
Volume 70 (2021): Issue 2 (September 2021)
Open Access
Options of Treatment in SARS-CoV-2 Infections
Alexandra Maria Cristea
Alexandra Maria Cristea
University of Medicine and Pharmacy “Carol Davila”
Bucharest, Romania
Marius Nasta Institute of Pneumoftiziology
Bucharest, Romania
Search for this author on
Sciendo
|
Google Scholar
Cristea, Alexandra Maria
,
Zaharia Dragos Cosmin
Zaharia Dragos Cosmin
University of Medicine and Pharmacy “Carol Davila”
Bucharest, Romania
Marius Nasta Institute of Pneumoftiziology
Bucharest, Romania
Search for this author on
Sciendo
|
Google Scholar
Cosmin, Zaharia Dragos
and
Bogdan Alexandru Miron
Bogdan Alexandru Miron
University of Medicine and Pharmacy “Carol Davila”
Bucharest, Romania
Search for this author on
Sciendo
|
Google Scholar
Miron, Bogdan Alexandru
Sep 27, 2022
Pneumologia
Volume 70 (2021): Issue 2 (September 2021)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Published Online:
Sep 27, 2022
Page range:
60 - 67
DOI:
https://doi.org/10.2478/pneum-2022-0013
Keywords
SARS-CoV-2
,
COVID-19
,
pandemics
© 2021 Alexandra Maria Cristea et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.